Rocket


News + Filings
IR Vault





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
CC transcript
Inv. presentation
Appointed director
Director departure
Credit agrmnt [a]
Asset disposition
Acq. announced
Appointed CFO
Consulting agrmnt
Auditor change
Notes underwriting agrmnt
Director comp.
Employment agrmnt
Dividend declared
Filed Chapter 11
Appointed COO
Monthly dividend
Preliminary results
Accel. buyback
Cert. of designation
Acq. completed
Monthly oper. report
Merger agrmnt [a]
Quarterly results presentation
Class action filed
CFO resigned
SSS news release
Departure of a VP
Asset acq. complete
Letter to company
Buyback announced
Bonus plan approved
Upcoming conference date
Notes have priced
Coll. bargaining agrmnt
10-Q late filing
RE purchase
Amended bylaws
New credit facility

All Companies Create: Portfolio | Alert

All | News | Filings
Date Filed  SymbolTypeDescription
09/30/2022    ****** 4 Mann Joshua (Director) has filed a Form 4 on SHF Holdings, Inc.
Txns: Converted 2,835,000 shares @ $0
Converted 2,835,000 options to buy @ $0
09/30/2022    ****** 4 Mann Joshua (Director) has filed a Form 4 on SHF Holdings, Inc.
Txns: Converted 2,835,000 shares @ $0
Converted 2,835,000 options to buy @ $0
09/30/2022    ****** 4 Darwin John (Director) has filed a Form 4 on SHF Holdings, Inc.
Txns: Converted 2,835,000 shares @ $0
Converted 2,835,000 options to buy @ $0
09/30/2022    ****** 4 Darwin John (Director) has filed a Form 4 on SHF Holdings, Inc.
Txns: Converted 2,835,000 shares @ $0
Converted 2,835,000 options to buy @ $0
09/30/2022    IDRA 4 WOOTEN RONALD J (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.
Txns: Acquired 5 shares @ $0
Acquired 1,343,547 warrants @ $0.46, valued at $618k
Acquired 14,115 warrants @ $460, valued at $6.5M
Acquired 14,115 options to buy @ $0
09/30/2022    ****** 4 WOOTEN RONALD J (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.
Txns: Acquired 5 shares @ $0
Acquired 1,343,547 warrants @ $0.46, valued at $618k
Acquired 14,115 warrants @ $460, valued at $6.5M
Acquired 14,115 options to buy @ $0
09/30/2022    IDRA 4 Taylor John Clayton (CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.
Txns: Granted 2,171,214 shares @ $0
Granted 22,810 options to buy @ $0
09/30/2022    ****** 4 Taylor John Clayton (CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.
Txns: Granted 2,171,214 shares @ $0
Granted 22,810 options to buy @ $0
09/30/2022    IDRA 4 Salain Daniel (COO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.
Txns: Granted 2,171,214 shares @ $0
Granted 22,810 options to buy @ $0
09/30/2022    ****** 4 Salain Daniel (COO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.
Txns: Granted 2,171,214 shares @ $0
Granted 22,810 options to buy @ $0
09/30/2022    IDRA 4 Kraus Carl N (Chief Medical Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.
Txns: Granted 651,364 options to buy @ $12.28, valued at $8M
Granted 6,843 options to buy @ $12280, valued at $84M
Granted 6,843 options to buy @ $0
09/30/2022    ****** 4 Kraus Carl N (Chief Medical Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.
Txns: Granted 651,364 options to buy @ $12.28, valued at $8M
Granted 6,843 options to buy @ $12280, valued at $84M
Granted 6,843 options to buy @ $0
09/30/2022    IDRA 4 JORDAN ANDREW R (Chief Strategy Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.
Txns: Granted 651,364 shares @ $0
Granted 6,843 options to buy @ $0
09/30/2022    ****** 4 JORDAN ANDREW R (Chief Strategy Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.
Txns: Granted 651,364 shares @ $0
Granted 6,843 options to buy @ $0
09/30/2022    IDRA 3 WOOTEN RONALD J (Director) has filed a Form 3 on IDERA PHARMACEUTICALS, INC.
09/30/2022    ****** 3 WOOTEN RONALD J (Director) has filed a Form 3 on IDERA PHARMACEUTICALS, INC.
09/30/2022    IDRA 3 Taylor John Clayton (CEO) has filed a Form 3 on IDERA PHARMACEUTICALS, INC.
09/30/2022    ****** 3 Taylor John Clayton (CEO) has filed a Form 3 on IDERA PHARMACEUTICALS, INC.
09/30/2022    IDRA 3 Kraus Carl N (Chief Medical Officer) has filed a Form 3 on IDERA PHARMACEUTICALS, INC.
09/30/2022    ****** 3 Kraus Carl N (Chief Medical Officer) has filed a Form 3 on IDERA PHARMACEUTICALS, INC.
09/30/2022    IDRA 3 JORDAN ANDREW R (Chief Strategy Officer) has filed a Form 3 on IDERA PHARMACEUTICALS, INC.
09/30/2022    ****** 3 JORDAN ANDREW R (Chief Strategy Officer) has filed a Form 3 on IDERA PHARMACEUTICALS, INC.
09/30/2022    IDRA 3 Salain Daniel (COO) has filed a Form 3 on IDERA PHARMACEUTICALS, INC.
09/30/2022    ****** 3 Salain Daniel (COO) has filed a Form 3 on IDERA PHARMACEUTICALS, INC.
09/30/2022    ****** 4 5AK, LLC (10% Owner) has filed a Form 4 on SHF Holdings, Inc.
Txns: Converted 2,835,000 shares @ $0
Converted 2,835,000 options to buy @ $0
09/30/2022    ****** 4 5AK, LLC (10% Owner) has filed a Form 4 on SHF Holdings, Inc.
Txns: Converted 2,835,000 shares @ $0
Converted 2,835,000 options to buy @ $0
09/30/2022    ****** 4 English Aron R. (10% Owner) has filed a Form 4 on Anebulo Pharmaceuticals, Inc.
Txns: Granted 1,703,577 shares @ $2.81, valued at $4.8M
Granted 30,425 options to buy @ $6, valued at $182.6k
Granted 1,703,577 options to buy @ $4.215, valued at $7.2M
09/30/2022    ****** 4 English Aron R. (10% Owner) has filed a Form 4 on Anebulo Pharmaceuticals, Inc.
Txns: Granted 1,703,577 shares @ $2.81, valued at $4.8M
Granted 30,425 options to buy @ $6, valued at $182.6k
Granted 1,703,577 options to buy @ $4.215, valued at $7.2M
09/30/2022    ANEB 4 English Aron R. (10% Owner) has filed a Form 4 on Anebulo Pharmaceuticals, Inc.
Txns: Granted 1,703,577 shares @ $2.81, valued at $4.8M
Granted 30,425 options to buy @ $6, valued at $182.6k
Granted 1,703,577 options to buy @ $4.215, valued at $7.2M
09/30/2022    ****** 4 Torres Peter Lansing (Director) has filed a Form 4 on SHF Holdings, Inc.
Txns: Converted 10,000 shares @ $0
Converted 10,000 options to buy @ $0
09/30/2022    ****** 4 Torres Peter Lansing (Director) has filed a Form 4 on SHF Holdings, Inc.
Txns: Converted 10,000 shares @ $0
Converted 10,000 options to buy @ $0
09/30/2022    IRTC 4 Devine Douglas (COO) has filed a Form 4 on iRhythm Technologies, Inc.
Txns: Sold 2,000 shares @ $125, valued at $250k
09/30/2022    ****** 4 Devine Douglas (COO) has filed a Form 4 on iRhythm Technologies, Inc.
Txns: Sold 2,000 shares @ $125, valued at $250k
09/30/2022    PRTA 4 Kinney Gene G. (President and CEO) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO
Txns: Sold 1,045 shares @ $48.09, valued at $50.3k
Sold 128 shares @ $49.41, valued at $6.3k
Sold 552 shares @ $51.2999, valued at $28.3k
Sold 2,333 shares @ $52.4397, valued at $122.3k
Sold 5,852 shares @ $53.3966, valued at $312.5k
Sold 4,748 shares @ $54.376, valued at $258.2k
Sold 1,342 shares @ $55.3236, valued at $74.2k
Sold 40 shares @ $56.1915, valued at $2.2k
Sold 243 shares @ $57.7031, valued at $14k
Sold 129 shares @ $58.93, valued at $7.6k
Exercised 16,412 options to buy @ $6.41, valued at $105.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy